Navigation Links
NIST, NCI, SAIC partner on new method for detecting HER2 breast cancer
Date:2/19/2008

Generations of mothers have served up chicken soup to remedy the common cold, but now the therapeutic fowl may find use in diagnosis as well. Researchers at the National Institute of Standards and Technology (NIST), the National Cancer Institute (NCI) and the scientific research firm SAIC recently showed how chicken antibodies may one day improve the detection of an aggressive form of breast cancer.

HER2 is one of a family of genes that help regulate the growth and proliferation of human cells. Normal cells have two copies of HER2, but about 20 to 25 percent of breast cancers have multiple copies of the gene, resulting in the overproduction of a HER2-encoded protein (called HER2) that stimulates tumors to be particularly fast growing and difficult to treat in a subset of breast cancer patients.

Patients with that form of breast cancerabout 40,000 women in the United States annuallycan be treated with a monoclonal antibody called trastuzumab that targets and inhibits the growth of tumor cells with higher-than-normal levels of the HER2 protein. But because the treatment can have adverse side effects, its important to screen for those patients who would benefit from it by testing them for one or both of the two relevant biomarkers: the amplified HER2 gene or its overexpressed HER2 protein. Unfortunately, the existing tests for these biomarkers can yield a significant number of false positivesas many as 23 percent of patients in one 2006 clinical studyresulting in some women getting a somewhat risky and expensive treatment that cant help them.

In a paper in the International Journal of Cancer,* the NIST-NCI-SAIC research team found that chicken immunoglobulin Y (IgY) antibody created against the HER2 protein could be tagged with quantum dot (tiny, intense and tunable sources of colorful light) to more reliably detect the HER2 biomarker than the existing diagnostic tests using mammalian antibodies tagged with conventiona
'/>"/>

Contact: Michael E. Newman
michael.newman@nist.gov
301-975-3025
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. 24 Hour Fitness Partners With Derek Jeter to Launch Signature Sports Clubs in New York City
2. The Leukemia & Lymphoma Society and the Nations Triathlon Announce New Partnership
3. WeissComm Partners Names Tom Jones Managing Director to Deepen Global Product Communications Offering
4. Paine & Partners, LLC Announces Sale of Byram Healthcare to OPG Groep N.V.
5. Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Have Been Filed Against American Dental Partners, Inc.
6. CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
7. Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners
8. DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference
9. Michigan-Based Businesses Partner to Increase Dental Coverage Access for Medicare Beneficiaries
10. AIDS Healthcare Foundation and NCHADS Partnership Adds 8th Cambodian AIDS Treatment Center in Kirivong
11. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIST, NCI, SAIC partner on new method for detecting HER2 breast cancer
NIST, NCI, SAIC partner on new method for detecting HER2 breast cancer
(Date:11/27/2009)...FRANCISCO, Nov. 27 The G...t Blair Lambert, CFO/COO, will present at the NASD...t the May Fair Hotel in London, England, on Wednes... listen to a live broadcast of The Gymboree Corpor... on to www.gymboree.com, click on "Our Company" at...
(Date:11/27/2009)...ling plus low-emission vehicles may reduce future ...AY, Nov. 27 (HealthDay News) -- Encouraging city d...would offer much greater public health benefits th...esearchers have found. , The study compared the...rban land transport scenarios for London, England,...
(Date:11/27/2009)... Specialist manufacturers who use medica...ving millions of dollars by bringing in technology...easing numbers of pro-active medical manufacturers...oncept stage of their projects, ensuring that prog...ocesses or potentially outdated technology. , ...
(Date:11/26/2009)...questering drug tetrathiomolybdate (TM) has been s...f Wilson disease, a disease caused by an overload ...ch is known. Very little, however, is known about ...ew study led by Northwestern University researcher...imensional structure of TM bound to copper-loaded ...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a ...olina, today announced the expansion of its servic...ntist, Dr. Doug Macmillan. , ...tal is pleased to announce that Dr. Doug Macmillan...pleted an additional advanced training seminar. R...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...ry Epidemiology Unit Director Dr Nihal Abeysinghe ... poultry products from India. This is due to the r...fection death in India. // They are requesting the...ncreased chance of it being spread to Lanka. Howe...
...level of mercury exposure during pregnancy does no...and teenagers. // The result of the study was pres...ent of Science meeting held recently in St. Louis.... of the mothers belonged to areas close to the Ind...
...struction caused by the Indian Ocean tsunami, the ...thquake in late 2005. The tsunami was responsible ...an 100,000 still missing.// When the early images ...es to sport a video camera at the time! Infact the...
... doing the rounds amongst the media and the genera... time to dissect these theories, and ascertain the...inaccurate assumptions surrounding autism. A p...ypes that have gained popularity. These stereotype...
...inst the use of Teflon. The Environmental Protecti... a main ingredient used to make the substance nons...ound that when the coated cookware was heated to m...first to figure out how to make a nonstick surface...
...tistry of New Jersey a state medical school is in ...d Bruce C. Vladeck a nationally recognized health .... // Vladeck was in charge of Medicare and Me...ay the federal government $4.9 million after ackno...
Other Medicine News:Health News:Bird flu affects the export of poultry products to Sri Lanka and Nepal 2Health News:Autism: Symposium to Discuss Myths and Misconceptions 2
(Date:11/25/2009)... JOHANNESBURG, November 25 ,iThemba...very announced today,that they have signed a colla...s, services. , Pyxis,s world class comput...l be coupled with iThemba,s service division to pr... projects identified through Pyxis,international ...
(Date:11/25/2009)...Newswire/ -- ChemoCentryx, Inc., announced today...s PROTECT-1 (the Prospective Randomized Oral Thera...t-EN(TM) (CCX282-B) in patients with moderate-to-s...cy with a favorable safety and tolerability profil...ficacy in the reduction of disease severity as def...
(Date:11/24/2009)... -- ,, WHAT: Rom Houbens, a Belgian man thoug...auto accident, was actually fully conscious and aw... Morning America segment. The DynaVox EyeMax was ...ith Locked-in Syndrome and other conditions can un...ica -- Tuesday, November 24 available online at ...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Research Finds New Crop of Breast Cancer Genes 47543 1Research Finds New Crop of Breast Cancer Genes 47543 2New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations 47540 1New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations 47540 2Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 1Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 2Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 3Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 4Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 5
...eral,Hospital Vienna successfully completed its fi...ment. The hospital is one of the first in the worl...tion., (Logo: http://www.newscom.com/cgi-bin/prn...s a simultaneous control of the linear,accelerator...f the,multileaf collimator and dose rate. This fle...
...for the first time that embryonic stem cells can b...lls, a finding which is an important step,in the u...ve source of,cells for bone marrow transplantation... and immune disorders, who need these transplants ...he official journal of the,American Society of Hem...
Other Medicine Technology:First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna 2First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna 3A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds 2A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds 3
Physiological Stress Loaded (P.S.L.) Stem
S-ROM Femoral Stems - Long Length Stems 36mm Neck with 21mm Calcar Replacement + Lat Neck
WG-1-10xx Revision Quatroloc Femoral Stems
AcuMatch C-Series LONG STEM
Medicine Products: